Roivant Sciences Ltd. (ROIV)
26.46
-0.29
(-1.08%)
USD |
NASDAQ |
Feb 13, 10:45
Roivant Sciences Profit Margin (Quarterly) : -15.69K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Immunovant, Inc. | -- |
| GSK Plc | 8.44% |
| Kiniksa Pharmaceuticals International Plc | 10.19% |
| Silence Therapeutics Plc | -13.18K% |
| Adaptimmune Therapeutics Plc | -221.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -19.87% |
| Return on Assets | -18.95% |
| Return on Invested Capital | -19.48% |
| Gross Profit Margin (Quarterly) | 30.42% |
| Operating Margin (Quarterly) | -16.97K% |
| Return on Net Operating Assets | -876.9% |